GlassScriptPhysician profile
Bruce R Werber
NPI 1154315174
$176,840.15
in general payments reported to CMS, 2019-2025
6 companies · $783 in 2025
The $783 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,315 · 2020: $1,905 · 2021: $313 · 2022: $1,500 · 2023: $92K · 2024: $78K · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $171K · Food and Beverage: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $170,783.06 |
| Food and Beverage | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $167,781.47 | 2022-2024 | Allograft |
| Acumed LLC | $4,501.59 | 2024-2025 | Osteomed |
| Osteomed LLC | $3,302.02 | 2019-2021 | |
| Arthrosurface Incorporated | $1,200.00 | 2020 | |
| Exactech, INC. | $31.07 | 2019 | |
| Arthrex, INC. | $24.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Werber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.